FMP
Blue Water Vaccines, Inc.
BWV
NASDAQ
Inactive Equity
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
0.18 USD
-0.0135 (-7.49%)
We are unable to load the chart at this time.
Dr. Neil J. Campbell MA, MBA
Healthcare
Biotechnology
NASDAQ
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
0001782107
US09610B1089
09610B108
201 East Fifth Street
513 620 4101
US
12
Feb 18, 2022
We are unable to load the chart at this time.
We are unable to load the chart at this time.
0001782107
NASDAQ
Biotechnology
Healthcare
09610B108
US09610B1089
US
0.18
0
435.53k
3.41M
-
0.1601-1.95
2.1
-
-
-
-
-0.17
-
https://www.bluewatervaccines.com
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.